Evidence map›Paper›PMID 35366134›Full record

ArticleBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2023

The synthesis and properties of mitochondrial targeted iron chelators.

Agostino Cilibrizzi, Charareh Pourzand, Vincenzo Abbate, Olivier Reelfs, Laura Versari, Giuseppe Floresta, Robert Hider

Abstract read
In one paragraph

Article in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. The role of mitochondria in iron overload-induced damage.Journal of translational medicine · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agostino CilibrizziInstitute of Pharmaceutical Science, King's College London, London, UK.
Charareh PourzandDepartment of Pharmacy and Pharmacology, University of Bath, Bath, UK.
Vincenzo AbbateInstitute of Pharmaceutical Science, King's College London, London, UK.
Olivier ReelfsDepartment of Pharmacy and Pharmacology, University of Bath, Bath, UK.
Laura VersariInstitute of Pharmaceutical Science, King's College London, London, UK.
Giuseppe FlorestaInstitute of Pharmaceutical Science, King's College London, London, UK.
Robert HiderInstitute of Pharmaceutical Science, King's College London, London, UK. robert.hider@kcl.ac.uk.ORCID http://orcid.org/0000-0003-1330-5797

Funding

Biotechnology and Biological Sciences Research Council BB/J005223/1Parkinson's UK K-1603
6 · The paper itself

Abstract

Iron levels in mitochondria are critically important for the normal functioning of the organelle. Abnormal levels of iron and the associated formation of toxic oxygen radicals have been linked to a wide range of diseases and consequently it is important to be able to both monitor and control levels of the mitochondrial labile iron pool. To this end a series of iron chelators which are targeted to mitochondria have been designed. This overview describes the synthesis of some of these molecules and their application in monitoring mitochondrial labile iron pools and in selectively removing excess iron from mitochondria.

Indexed as

Iron Chelating AgentsIron OverloadHumansIronMitochondriaReactive Oxygen SpeciesIronIron Chelating AgentsReactive Oxygen SpeciesChelator synthesisIron chelationIron-probeMitochondria

Identifiers

PMID35366134
PMCPMC10082125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.